The company’s proprietary EVADER vectors, which consist of enveloped AAV particles engineered with potent, checkpoint immunosuppressive molecules, overcome some of the key immunological ...

A new, streamlined AAV purification process that is both universal and scalable could ease commercialization constraint.

In 2014, researchers combined DNA barcoding with next-generation sequencing (NGS) to develop the adeno-associated virus (AAV) barcode-seq technology for streamlining AAV screening. Using this method, ...

Adeno-associated vectors (AAV) have become the workhorse for gene therapy delivery over the last two decades. With the constantly growing number of clinical trials, the demand for vectors has ...

Patients with CTNNB1 Syndrome will benefit from this joint effort to develop and manufacture a new AAV investigational gene therapy, which aims to restore gene function and may improve quality of ...